Phenylephrine Impurity 27, identified by its CAS number 2575516-76-4, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of drug formulation and quality control. As an impurity, it may arise during the synthesis of phenylephrine, a common decongestant and vasopressor. The characteristics of this impurity can include its molecular structure, which may differ from the parent compound, leading to variations in its physical and chemical properties such as solubility, stability, and reactivity. Impurities like Phenylephrine Impurity 27 are often analyzed using techniques such as chromatography and mass spectrometry to ensure the purity of pharmaceutical products. Understanding the characteristics of such impurities is crucial for regulatory compliance and ensuring the safety and efficacy of medications. Additionally, the presence of impurities can affect the pharmacokinetics and pharmacodynamics of the active pharmaceutical ingredient, making their identification and quantification essential in drug development and quality assurance processes.

Phenylephrine Impurity 27

2575516-76-4: Phenylephrine Impurity 27, identified by its CAS number 2575516-76-4, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of drug formulation and quality control. As an impurity, it may arise during the synthesis of phenylephrine, a common decongestant and vasopressor. The characteristics of this impurity can include its molecular structure, which may differ from the parent compound, leading to variations in its physical and chemical properties such as solubility, stability, and reactivity. Impurities like Phenylephrine Impurity 27 are often analyzed using techniques such as chromatography and mass spectrometry to ensure the purity of pharmaceutical products. Understanding the characteristics of such impurities is crucial for regulatory compliance and ensuring the safety and efficacy of medications. Additionally, the presence of impurities can affect the pharmacokinetics and pharmacodynamics of the active pharmaceutical ingredient, making their identification and quantification essential in drug development and quality assurance processes.

CAS 2575516-76-4

Phenylephrine Impurity 27

(1R,4R)-1,2,3,4-Tetrahydro-4,6-dihydroxy-1-(3-hydroxyphenyl)-2-methylisoquinoline

Ref: 86-MM0081.27